CMS has announced a series of Medicare Evidence Development & Coverage Advisory Committee (MedCAC) meetings to address specific Medicare coverage issues. MedCAC is meeting October 21, 2009 to focus on the use of catheter ablation for the treatment of atrial fibrillation. On November 11, 2009, MedCAC will address the adequacy of the available evidence that supports the diagnostic and treatment methods used in the management of secondary lymphedema. On January 27, 2010, the panel will review the evidence that supports the use of pharmacogenomic testing in the diagnosis and treatment of cancer. MedCAC also will meet on March 24, 2010, to examine the available evidence on the use of erythropoiesis stimulating agents (ESAs) to manage anemia in patients who have chronic kidney disease.